WAYNE, Pa., Aug. 21, 2023 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today...
– Cabozantinib in combination with atezolizumab demonstrated a statistically significant reduction in the risk of disease progression or death compared...
— Randomized, double-blind, controlled trial met primary endpoint of durable response rate and all secondary endpoints — — Overall safety consistent...
LAS VEGAS, NV / ACCESSWIRE / August 21, 2023 / Cancer Partners of Nebraska, a leading healthcare provider specializing in...
Approval based on the pivotal PULSAR and PHOTON trials in which EYLEA® HD demonstrated clinically equivalent vision gains to EYLEA...
Irvine, Aug. 18, 2023 (GLOBE NEWSWIRE) -- Results The Company reported net income of $176,427 or $0.01 per basic and...
VANCOUVER, BC / ACCESSWIRE / August 18, 2023 / EMPOWER CLINICS INC (CSE:EPW)(OTC PINK:EPWCF) ("Empower" or the "Company") an integrated...
Madison, Wisconsin--(Newsfile Corp. - August 18, 2023) - Building on Wisconsin's statewide position of strength in personalized medicine, biohealth technology,...
First stem cell clinical trial landscape is revolutionized by Beauty-Stem Biomedical and Taiwan Tzu Chi Hospital, unveiling the progress of...
FORT LAUDERDALE, FL / ACCESSWIRE / August 18, 2023 / Outcome Engenuity (OE) is excited to announce the appointment of...
Updated COVID-19 vaccine effectively targets EG.5, a dominant variant of concern, as well as the rapidly spreading FL 1.5.1 variantUpdated...
eClinicalWorks population health solutions streamline patient data for Connecticut Institute for Communities, Inc.WESTBOROUGH, Mass.--(BUSINESS WIRE)--eClinicalWorks®, the largest ambulatory cloud EHR,...
American Heart Association consortium advances development of evidence-based health tech solutionsAUSTIN, Texas--(BUSINESS WIRE)--Found, a medically-assisted weight loss program, today announced...
PRINCETON, NJ / ACCESSWIRE / August 17, 2023 / On August 9, Agile Therapeutics (NASDAQ:AGRX) released its second-quarter financial results,...
Record Q2 2023 revenue of $10.9M, an increase of 205% from Q2 2022Record Q2 2023 income from operations of $235K,...
Company on track to report top line data in late October 2023SAN FRANCISCO, CA / ACCESSWIRE / August 17, 2023...
European Patent Allowed for Quantification by an ECG of Key Heart Measures using AISouthlake, TX, Aug. 17, 2023 (GLOBE NEWSWIRE)...
TARRYTOWN, N.Y., Aug. 17, 2023 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the European Medicines Agency...
Loughborough, England, Aug. 17, 2023 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (Nasdaq: NMRD) (“Nemaura” or the “Company”), a medical technology...
Reports progress towards global supply chain development Ended the second quarter of 2023 with cash, cash equivalents, restricted cash and...